Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase - PubMed (original) (raw)

Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase

A D Reith et al. EMBO J. 1991 Sep.

Abstract

Germline mutations at the Dominant White Spotting (W) and Steel (Sl) loci have provided conclusive genetic evidence that c-kit mediated signal transduction pathways are essential for normal mouse development. We have analysed the interactions of normal and mutant W/c-kit gene products with cytoplasmic signalling proteins, using transient c-kit expression assays in COS cells. In addition to the previously identified c-kit gene product (Kit+), a second normal Kit isoform (KitA+) containing an in-frame insertion, Gly-Asn-Asn-Lys, within the extracellular domain, was detected in murine mast cell cultures and mid-gestation placenta. Both Kit+ and KitA+ isoforms showed increased autophosphorylation and enhanced association with phosphatidylinositol (PI) 3' kinase and PLC gamma 1, when stimulated with recombinant soluble Steel factor. No association or increase in phosphorylation of GAP and two GAP-associated proteins, p62 and p190, was observed. The two isoforms had distinct activities in the absence of exogenous soluble Steel factor; Kit+, but not KitA+, showed constitutive tyrosine phosphorylation that was accompanied by a low constitutive level of association with PI-3' kinase and PLC gamma 1. Introduction of the point substitutions associated with W37 (Glu582----Lys) or W41 (Val831----Met) mutant alleles into c-kit expression constructs abolished (W37) or reduced (W41) the Steel factor-induced association of the Kit receptor with signalling proteins in a manner proportional to the overall severity of the corresponding W mutant phenotype. These data suggest a diversity of normal Kit signalling pathways and indicate that W mutant phenotypes result from primary defects in the Kit receptor that affect its interaction with cytoplasmic signalling proteins.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell. 1987 Sep 25;50(7):1021-9 - PubMed
    1. EMBO J. 1987 Nov;6(11):3341-51 - PubMed
    1. Cell. 1988 Oct 7;55(1):185-92 - PubMed
    1. Nature. 1988 Sep 1;335(6185):88-9 - PubMed
    1. EMBO J. 1988 Apr;7(4):1003-11 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources